ロード中...
Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
Interferon-alpha (IFNα) has been used to treat chronic hepatitis C virus (HCV) infection for over 20 years with varying efficacy, depending on the infecting viral genotype. The mechanism of action of IFNα is not fully understood, but is thought to target multiple stages of the HCV lifecycle, inhibit...
保存先:
| 出版年: | Hepatology |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BlackWell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4265257/ https://ncbi.nlm.nih.gov/pubmed/25066844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27333 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|